@techcrunch.com 1 year ago
Barcelona’s Impress heads towards a $125M Series B round in its bid to digitize orthodontics
@theverge.com 7 years ago
UK patients could wait a year longer for new drugs after Brexit
@techcrunch.com 9 years ago
Amid ‘Right To Try’ Debate, myTomorrows Raises €4.5M To Give Patients Access To Development-Stage Drugs